● Recruiting

Safety and Potential Effect of Innovative Treatment by Adjuvant Injection of Stromal Vascular Fraction From Autologous Adipose Tissue of URethral Stenosis With Endoscopic Urethrotomy

Condition: Urethral Stenosis · Sponsor: Assistance Publique Hopitaux De Marseille

PhasePhase 2

Planned participants20

Who can joinMale, 18 Years to 85 Years

Healthy volunteersNo

About this study

SURF is a randomised controlled, parallel group, single blind phase II study designed to assess the safety and potential efficacy of an innovative therapeutic strategy for urethral stenosis based on adjuvant injection of autologous Adipose-Derived Stromal Vascular Fraction of Adipose Tissue (ADSVF) during endoscopic urethrotomy (standard care).

This description comes directly from the study's public registry record.

Talk to the study team

Gilles Karsenty, Pr. · 0491435170 · Gilles.KARSENTY@ap-hm.fr

Alexandra GIULIANI · 0491382870 · alexandra.giuliani@ap-hm.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Assistance Publique Hopitaux de Marseille

Marseille, France

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05857371